Literature DB >> 17291045

Anti-HCV bioactivity of pseudoguaianolides from Parthenium hispitum.

Jin-Feng Hu1, Rupal Patel, Bin Li, Eliane Garo, Grayson W Hough, Matt G Goering, Hye-Dong Yoo, Mark O'neil-Johnson, Gary R Eldridge.   

Abstract

Five new (1-5) and four known (6-9) C14-oxygenated 1alpha-hydroxy-11(13)-pseudoguaien-6beta,12-olides with potent inhibition of hepatitis C virus (HCV) replication were obtained from Parthenium hispitum via high-throughput natural product chemistry methods. A semipreparative HPLC system was used to purify these compounds. The miniaturization of the structure elucidation and dereplication for the mass-limited samples were performed primarily utilizing a capillary-scale NMR probe. Compounds 2-4 were found to possess in vitro anti-HCV activity in the subgenomic HCV replicon system containing luciferase reporter with significant inhibition above 90% at 2 microM concentration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17291045     DOI: 10.1021/np060567e

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  2 in total

1.  Identification and evaluation of anti hepatitis C virus phytochemicals from Eclipta alba.

Authors:  Dinesh Manvar; Mahesh Mishra; Suriender Kumar; Virendra N Pandey
Journal:  J Ethnopharmacol       Date:  2012-09-28       Impact factor: 4.360

Review 2.  Natural products as promising drug candidates for the treatment of hepatitis B and C.

Authors:  Carolin Wohlfarth; Thomas Efferth
Journal:  Acta Pharmacol Sin       Date:  2008-12-08       Impact factor: 6.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.